Join
Live feed
·
PRReleasevia Quantisnow
BridgeBio Pharma Inc. logo
Eidos Therapeutics, Inc. logo

Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.), EIDX (Eidos Therapeutics, Inc.) and more on Quantisnow.